Storage | Store at 4°C |
Description | This product utilizes the lipid nanoparticle (LNP) technology platform for simple and efficient delivery of the Nucleocapsid protein (COVID-19) mRNA to a variety of mammalian cells, including cell cultures which may typically be prone to difficulties in expressing desired proteins. The lipid nanoparticles used are formulated with, SM-102, DSPC, cholesterol, and DMG-PEG2000 at optimal molar concentration for a high rate of encapsulation and efficient mRNA delivery. The COVID-19 Nucleocapsid is a multifunctional protein that has been shown to form complexes with genome RNA. Studies have highlighted its ability to interact with viral membrane proteins during virion assembly and its role in enhancing the efficiency of virus transcription and assembly. This ability has rendered the Nucleocapsid protein a candid vice for mRNA delivery. mRNA encapsulated in lipid nanoparticle, primarily in PBS (-ca, -mg). Dilute levels of: sodium acetate, ethanol, free mRNA & free lipids. |
Lipid composition | SM-102/DSPC/cholesterol/DMG-PEG2000 |
Technical Notes | Work with mRNA-LNP on ice. It is important to minimize the time that the product spends at room temperature; after handling product during experiments, return immediately to ice. Upon receiving product, briefly pulse spin before opening to ensure product is at bottom of container; it is important not to spin for too long as this may rupture mRNA-LNP’s. Do not vortex. mRNA-LNP products should only be handled with certified RNAase-free reagents and consumables; use of filtered pipette tips is highly recommended. |
Usage | 1. Prior to transfection, in a 12 well culture plate, plate your cells at [0.5E6 cells/mL] in a total of 1 mL per well. Ensure the cells you are using are viable and healthy. Try not to let your cells sit for longer than 5 minutes prior to transfection; cell clumping at the time of transfection may reduce transfection efficiency. 2. Briefly pipette mRNA-LNP solution up and down to resuspend. Add 20 uL of the mRNA-LNP mix dropwise directly to your 1 mL culture. Gently tilt plate back and forth to mix (not necessary if you are using cells which will be immediately placed back into a shaker). Place your transfected cells back into their original culture conditions. 3. Check cell expression by FACS at 24hr intervals after transfection. *Note: This is a generalized protocol for transfection using mammalian cells. Transfection volume may be scaled down/up proportionately. |
Encoding mRNA | COVID-19 Nucleocapsid protein |
In Vitro QC (Cell Types) | HEK293S |
Technology Applications | Vaccine development |
Required fields are marked with *
×Product Name | Catalog | Lipid composition | Liposome Size | Price |
---|---|---|---|---|
Clipos™ COVID-19 Nucleocapsid Protein mRNA Lipid Nanoparticles | CDL23-079-L | SM-102/DSPC/Cholesterol/DMG-PEG2000 | $1595 | |
Clipos™ COVID-19 Nucleocapsid Protein mRNA Lipid Nanoparticles | CDPM04 | SM-102/DSPC/cholesterol/DMG-PEG2000 | INQUIRY | |
Clipos™ COVID-19 Nucleocapsid Protein mRNA Lipid Nanoparticles | CDL23-056-L | SM-102/DSPC/Cholesterol/DMG-PEG2000 | $1595 | |
Clipos™ COVID-19 Nucleocapsid Protein mRNA Lipid Nanoparticles | CDSNT62 | $1380 | ||
Clipos™ COVID-19 Nucleocapsid Protein mRNA Lipid Nanoparticles | CDPM11 | SM-102/DSPC/cholesterol/DMG-PEG2000 | INQUIRY | |
Clipos™ COVID-19 Nucleocapsid Protein mRNA Lipid Nanoparticles | CDL23-083-L | SM-102/DSPC/Cholesterol/DMG-PEG2000 | $1595 | |
Clipos™ COVID-19 Nucleocapsid Protein mRNA Lipid Nanoparticles | CDL23-033-L | SM-102/DSPC/Cholesterol/DMG-PEG2000 | $1980 | |
Clipos™ COVID-19 Nucleocapsid Protein mRNA Lipid Nanoparticles | CDPM09 | SM-102/DSPC/cholesterol/DMG-PEG2000 | INQUIRY |
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.